Searched for
PHARMACEUTICAL MNC
IT a tactical buy; Devarsh Vakil reveals 5 sectors worth buying as markets turn volatileLeading analyst Devarsh Vakil suggests Indian markets offer compelling buying opportunities now, with valuations correcting to attractive l...- India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Time to buy? Sunny Agrawal finds best picks across banking, pharma, capital markets & infrastructureIndian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%Around two decades ago, as Indian pharma firms first began to move into the US market, they faced many challenges, the biggest of which was...
- MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...
- Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
- Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...
- Stock pick of the week: Recent dip in Abbott India price offers entry point to long-term investorsAbbott India is expected to end 2020-21 with revenue and net profit growth of 11% and 18% respectively. Besides, its debt-free status along...
- Abbott Labs up 100% in 15 months, still not expensive: Mehraboon IraniLooking at the numbers, which the management was talking about, the stock still does not look very expensive, says Irani.
- Job of the week: Manager/Senior Manager-Programme Management-Custom Research & Manufacturing ServicesEvery Tuesday, we will bring you a glimpse into the hottest jobs of the season.
- MNC funds underperform in recent rallyEquity mutual funds investing in multi national companies have underperformed the broad markets, in the last one month.
- Investors queue up for MNC pharma companies; GlaxoSmithKline Pharma, Pfizer riseInvestors were seen flocking to the counters of select MNC pharma companies which have emerged as defensive bets amid choppy market conditi...
- Cadila, Torrent pharma preferred stocks in pharmaceutical space: Sharmila JoshiSharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services in an interview with ET Now talks about pharmaceutical stocks.
- Local pharma cos beat MNC peersDomestic pharmaceutical shares have outperformed their multinational (MNC) counterparts in the last month, even as the MNCs have done some ...
Load More
